How weight-loss drugs Ozempic and Wegovy were developed and the scientists behind them
Developed to treat diabetes, drugs like Ozempic now help fight obesity. Scientists newly honoured for working on them recall ...
Severe obesity is on the rise in the US, according to new research
The U.S. obesity rate is about 40%, according to a 2021-2023 survey of about 6,000 people. Nearly 1 in 10 of those surveyed ...
Obesity among adults falls slightly to 40%, still higher than a decade ago
More than 100 million American adults have obesity and more than 20 million adults have severe obesity, U.S. figures show.
Severe Obesity Is on the Rise in the US
Obesity is high and holding steady in the U.S. About 4 in 10 Americans have obesity overall and about 1 in 10 have severe ...
'Truth will be out soon': The GOAT actress Parvati Nair BREAKS SILENCE on accusations of assaulting domestic help; issues statement
The GOAT actress Parvati Nair has finally addressed the rumors circulating that she allegedly assaulted her domestic help.
7 Reasons to include Avocado in your weight loss diet
With increasing inclination towards health and fitness, people are gradually moving towards healthier options, and avocado is ...
ABC Action News2h
The maker of Wegovy and Ozempic will testify about the price of the drugs
Lawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can ...
Novo says Ozempic to be eligible for US price negotiations in less than a year
Jorgensen is set to testify before a Senate committee on Tuesday in a hearing focused on U.S. prices for its widely popular ...
Novo CEO to blame drug middlemen
The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...
Analysts say market forces will lower cost of obesity drugs
Hearing on weight loss drug prices will feature CEO of Novo Nordisk and comes after threats to subpoena company executives.
Maine woman sues Anthem insurance for failing to cover weight loss drugs
It's the second lawsuit to be filed this year in Maine against insurance carriers that limit coverage of popular drugs like ...
Becker's Hospital Review7h
Inside the GLP-1 'price war'
According to the Journal, the GLP-1 "pricing fight" began in late 2023, when Lilly priced Zepbound at $1,060 per month, or 20% lower than Novo Nordisk's Wegovy. Analysts told the newspaper that prices ...